Research Options:
Week of Expected Pricing Pending
Company Name Iaso pharma
Proposed Ticker IASO
CUSIP 44925K105
Business Description A biopharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment and prevention of infectious diseases.
Lead Underwriter Ladenburg Thalmann
Co-Managers Maxim Group LLC
Initial Shares 4000000
Revised Initial Shares N/A
Initial Price $4.50-$5.50
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.